SystImmune’s Licensing and Collaboration Agreement with Bristol Myers Squibb

Leila Ahmed
Tagged:

Cooley advised SystImmune on the transaction.SystImmune announced its exclusive license and collaboration agreement with Bristol Myers Squibb (NYSE: BMY) for SystImmune’s BL-B01D1. Under the terms of the…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

…

This content is for Standard 1 Year members only.
Login Join Now